Wound Care Biologics Market Observes an Outstanding Growth in Revenue of US$ 2.3 Billion by 2025 with CAGR of 6.9%
Wound Care Biologics Market |
During the anticipated years,
North America is anticipated to control the wound care biologics market. This
is primarily related to the region's increased burn injury cases and diabetes
population growth. Furthermore, one of the major factors anticipated to support
the expansion of the advanced Wound Care Biologics Market in the upcoming years is the
rising incidence of a number of lifestyle conditions that result in chronic
wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers.
The Wound
Care Biologics Market is crowded with major international players. For instance,
these goods are sold all over the world by ACell Inc., Integra LifeSciences
Corporation, Kerecis, Marine Polymer Technologies Inc., MiMedx Inc., Misonix,
Inc., Mölnlycke Health Care, Smith & Nephew PLC, and Wright Medical Group
NV.
Given that diabetic patients are
more likely to develop diabetic ulcers, the market for wound care biologics is
anticipated to grow significantly with the growth in the prevalence of diabetes
worldwide. According to the Global Diabetes Community, 642 million adults will
have diabetes worldwide by 2040, up from an estimated 422 million in 2017.
Peripheral neuropathy, foot ulceration, and peripheral arterial disease (PAD)
are twice as common in diabetic patients as they are in non-diabetics,
affecting 30% of diabetics aged 40 and older, according to the Journal of Foot
and Ankle Surgery, 2016. This has led to an increase in the burden of diabetic
complications.
Additionally, according to the
Advances in Wound Care Journal from 2015, 15% to 20% of people with diabetes
are likely to experience chronic, non-healing foot sores. In order to manage chronic
wounds affordably and lessen the financial burden of the patients, wound care
biologic products are offered to them.
The high cost of skin substitutes
and associated biologics, however, is a significant barrier to the Wound Care Biologics
Market expansion. For instance, the Advances in Skin Substitutes
Journal (2014) estimates that the cost of using Epicel to cover 1% of a body's
surface area will be more than $13,000. As a result, alternative and less
expensive wound care solutions are used more frequently, which is projected to
have a negative impact on market growth.
Over the course of the forecast,
Asia Pacific is anticipated to experience considerable expansion in the global Wound Care Biologics
Market. The high frequency of diabetes patients in Asian nations is
to blame for this. In 2016, the Indian Diabetes Research Foundation estimates
that 60% of people with diabetes live in Asia, with China and India accounting
for the majority of those cases. The Foundation also notes that Western Pacific
reported having more than 138.2 million diabetics, with a projected increase to
201.8 million by 2035.
Comments
Post a Comment